LONDON, Jan. 20, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:
The global market for active pharmaceutical ingredients has been growing steadily in recent years. However, the recent economic recession slowed down the growth of the industry as investments made by the major players went down significantly. Furthermore with a large number of blockbuster drugs going off patent by the year 2014, there is expected to be a major impact on the global API industry. Revenues of the API markets are likely to be affected as generic drugs take up the market.
The United States remains one of the biggest players in the market, followed closely by China and India. Synthetic pharmaceuticals also continue to dominate the API industry as biotech APIs move up slowly. Major companies such as Teva, Dr Reddy's and Boehringer Ingelheim continue to invest heavily in the API industry and remain the leading players in the global active pharmaceutical ingredient market.
Aruvian Research analyzes the global API industry in its research report Analyzing the Global Market for Active Pharmaceutical Ingredients. The report begins with an introduction to active pharmaceutical ingredients (APIs). An analysis of the global market for APIs includes an industry overview, industry revenues, industry segmentation by the biotech API market and the Synthetic API market and a profile of the High Potency Active Pharmaceutical Ingredient (HPAPAI) Market. We also analyze some of the major impacts on the global API market such as the ongoing and upcoming patent expiries of blockbuster drugs and the impact of the economic recession on the market.
An analysis of the market for APIs in Asia Pacific is carried out through an industry overview, analysis of industry revenues and industry segmentation, the therapeutic applications of APIs in Asia Pacific and the impacts on the industry. Key markets analyzed in Asia Pacific include China, India, Japan and South Korea.
An analysis of the market for APIs in Europe is carried out through an industry overview, analysis of industry revenues and industry segmentation, the therapeutic applications of APIs in Europe and the impacts on the industry. Key markets analyzed in Europe include France, Germany, Italy, Spain and the United Kingdom.
continue to read here